Kentron Biotechnology Plc

Kentron is a hybrid biotech company dedicated to providing quality and service excellence to pharmaceutical and biotechnology clients and their customers. Our core competency is clinical development of product candidate including licensing and technology transfer to manage product development programs and co marketing. Founded with the mandate to provide reliable, high-quality service at rates in line with disciplined corporate overhead, Kentron is driven to manage product development more effectively. This self-perpetuating business model whereby the quality of our work and reputation continuously attracts reputable clients and Kentron will be the common sense solution for the pharmaceutical, medical device and biotechnology industries. Our conviction is that excellent medical science underpins excellent clinical research and education. This is reflected in our ongoing collaborative relationship with the Research Department at the University of Kansas, We recognize that a significant part of our client base is in the USA and our North American office will open shortly. We are also progressing a major multiple oncology initiative, which will enable Kentron to deliver unparalleled speed, quality and prices for studies in all phases.